Happy 4th of July! Today, we celebrate the values that make our nation strong: freedom, independence, and unity.
ImmPACT Bio
Biotechnology Research
West Hills, California 7,369 followers
We are developing advanced therapies for cancer patients with critical unmet needs
About us
ImmPACT Bio USA, Inc., is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies that address key biological challenges in treating cancer and autoimmune diseases. Our technology is designed to precisely distinguish cancer and diseased cells from normal cells; thereby eliminating them without damaging normal tissues. The company was founded in 2017 in the FuturRx incubator (Israel). In 2019, ImmPACT Bio was incorporated in the US. In 2021 ImmPACT Bio merged with Kalthera. In 2022 we moved our Corporate offices to West Hills, CA and built a state-of-the-art clinical manufacturing facility.
- Website
-
immpactbio.com
External link for ImmPACT Bio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- West Hills, California
- Type
- Privately Held
- Founded
- 2017
- Specialties
- CAR-T, Immunotherapy, Cancer Therapy, On target off tumor toxicity , Selective treatment , Logic gate, Oncology, Biotechnology, Research, Immunotherapy, autoimmune, and lupus
Locations
-
Primary
Get directions
8501 Fallbrook Ave
200
West Hills, California 91304, US
-
Get directions
2 E.D.Bergman St.
Rehovot, IL
Employees at ImmPACT Bio
-
Ofir Goldberger 🧪
Biotech Corporate / Business Development and Licensing
-
Sheila Gujrathi, MD
Biotech Executive | Physician Scientist | Healthcare Investor | Drug Developer
-
Carolyn Gabus
Senior Director, Clinical Operations at ImmPACT Bio
-
Sumant Ramachandra, M.D., Ph.D.
CEO & Board Director at ImmPACT Bio
Updates
-
Yesterday we honored Juneteenth, the day ALL Americans became free. We celebrate the victories of the past and remain dedicated to pushing for a more equitable future. #juneteenth #progress #equality
-
-
Happy Pride Month from ImmPACT Bio! 🌈 Celebrating love, diversity, and equality. #PrideMonth, #DiversityAndInclusion, #MakeAnImmPACT
-
-
ImmPACT Bio is a proud sponsor of the upcoming LA Bioscience Ecosystem Summit Twenty24 (LA BEST 2024) hosted by the UCLA Technology Development Group on May 23, 2024. #LABest, #MakeAnImmPACT
-
-
We are pleased to announce that ImmPACT Bio will be presenting new preclinical data for our innovative CD19/20 bispecific CAR-T cell therapy, IMPT-514, at the upcoming Consortium of Multiple Sclerosis (MS) Centers Annual Meeting in Nashville, TN, from May 28 – June 1, 2024. 📅 Presentation Details: Title: Manufacturing of CD19/20 Bispecific CAR-T Cell Therapy (IMPT-514) for the Treatment of Multiple Sclerosis Abstract Number: LB04 Presenter: Ethan BenDavid, ImmPACT Bio Poster Session Date/Time: Thursday, May 30, 2024, from 5:15 – 7:15 PM ET Location: Music City Center, Exhibit Hall AB Read our press release: https://lnkd.in/gRxjTupN #ImmPACTBio #CAR_TCellTherapy #MultipleSclerosis #MSResearch #CMSC2024 #Biotechnology #Innovation #Healthcare
-
-
The ImmPACT Bio team recently attended the LuCIN Annual Meeting held by the Lupus Research Alliance. This inspiring event provided an opportunity for our team to meet with patients and share information about our clinical trials with the #lupus community. Thank you #TeamImmPACT https://lnkd.in/gma9dfAP #LupusAwarenessMonth #LupusClinicalResearch #MakeAnIMMPACT
-
-
Our team had a wonderful time at the American Society of Gene & Cell Therapy (ASGCT) conference presenting new preclinical data for our bispecific Claudin 18.2/TGF-β CAR T program. Thank you Jessica Reyes, Melanie Munguia, and Jenny Cui! #CARTcelltherapy, #MakeAnImmPACT
-
-
Welcome to the ImmPACT Bio team, Lauren M. and Edward Lee! #Welcometotheteam, #CARTcelltherapy, #MakeAnImmPACT
-
-
Our team had a great time celebrating Cinco de Mayo with a salsa contest! Congratulations to the winners! Happy Cinco de Mayo! #Cincodemayo, #MakeAnImmPACT
-
-
This month holds special significance as we shine a light on Lupus, a chronic autoimmune disease affecting millions worldwide. At ImmPACT Bio, we're dedicated to advancing research and developing innovative solutions to better understand and treat Lupus. To learn more about IMPT-514, the first-and-only CD19/CD20 CAR T-cell therapy in development for Systemic Lupus Erythematosus, visit our website at https://lnkd.in/gma9dfAP. Together, let's spread awareness, foster understanding, and work towards a future where Lupus no longer poses a barrier to living life to the fullest. 💜🦋 #LupusAwareness #MakeAnImmPACT
-